Preferred Label : Abiraterone Acetate;

MeSH definition : An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.;

MeSH hyponym : CB 7630; 17-(3-pyridyl)-5,16-androstadien-3beta-acetate; zytiga; CB-7630; CB7630;

MeSH Related Number : 154229-18-2;

Is substance : O;

UNII : EM5OCB9YJ6;

Details


Main resources

You can consult :

An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.

https://www.has-sante.fr/jcms/p_3477883/fr/akeega-niraparib/-acetate-d-abiraterone-cancer-de-la-prostate
2023
false
false
false
France
niraparib and abiraterone
insurance, health, reimbursement
treatment outcome
niraparib
drug combinations
Poly(ADP-ribose) Polymerase Inhibitors
antineoplastic agents
antineoplastic combined chemotherapy protocols
metastatic castration-resistant prostate cancer and BRCA 1/2 mutations in whom chemotherapy is not clinically indicated
neoplasm metastasis
administration, oral
evaluation of the transparency committee
Abiraterone Acetate
prostatic neoplasms

---
https://www.ema.europa.eu/en/medicines/human/EPAR/akeega
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
Abiraterone Acetate/Niraparib
Abiraterone Acetate/Niraparib
Abiraterone Acetate
Abiraterone Acetate
niraparib
niraparib
antineoplastic agents
antineoplastic agents
neoplasm metastasis
prostatic neoplasms, Castration-Resistant
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
adult
drug therapy, combination
prednisone
BRCA1 Gene Mutation
BRCA2 Gene Mutation
administration, oral
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Poly (ADP-Ribose) Polymerase-1
PARP2 protein, human
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Enzyme Inhibitors
steroid 17-alpha-hydroxylase
drug interactions
fertility
pregnancy
breast feeding
niraparib and abiraterone
drug evaluation, preclinical
metastatic castration-resistant prostate cancer and BRCA 1/2 mutations in whom chemotherapy is not clinically indicated

---
https://ansm.sante.fr/tableau-acces-derogatoire/niraparib-acetate-dabiraterone
2023
false
false
false
France
French
summary of product characteristics
package leaflet
drug combinations
administration, oral
Abiraterone Acetate/Niraparib
Abiraterone Acetate
niraparib
antineoplastic agents
guidelines for drug use
antineoplastic combined chemotherapy protocols
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
niraparib and abiraterone

---
https://www.has-sante.fr/jcms/p_3421297/fr/niraparib/acetate-d-abiraterone-janssen-cilag-cancer-de-la-prostate
2023
false
false
false
France
Abiraterone Acetate
insurance, health, reimbursement
drug combinations
antineoplastic agents
niraparib
Abiraterone Acetate/Niraparib
drug therapy, combination
prednisone
prednisolone
adult
neoplasm metastasis
metastatic castration resistant prostate cancer
BRCA1 Gene Mutation
BRCA2 Gene Mutation
prostatic neoplasms, Castration-Resistant
niraparib and abiraterone
evaluation of the transparency committee
prostatic neoplasms, Castration-Resistant

---
https://www.has-sante.fr/jcms/p_3470390/fr/ibiron-abiraterone-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Abiraterone Acetate
abiraterone
administration, oral
antineoplastic agents
antineoplastic combined chemotherapy protocols
metastatic castration resistant prostate cancer
neoplasm metastasis
adult
evaluation of the transparency committee
prostatic neoplasms

---
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-krka
2022
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Abiraterone Acetate
Abiraterone Acetate
treatment outcome
abiraterone
drugs, generic

---
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-mylan
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Abiraterone Acetate
Abiraterone Acetate
drugs, generic
administration, oral
antineoplastic agents
antineoplastic agents
Steroid Synthesis Inhibitors
Steroid Synthesis Inhibitors
prostatic neoplasms
neoplasm metastasis
Metastatic Prostate Carcinoma
drug therapy, combination
prednisone
prednisolone
Abiraterone/Prednisone Regimen
prostatic neoplasms, Castration-Resistant
neoplasms, hormone-dependent
metastatic castration resistant prostate cancer
abiraterone
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-accord
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
abiraterone
abiraterone
drug approval
europe
abiraterone
antineoplastic agents
antineoplastic agents
Abiraterone Acetate
Abiraterone Acetate
prostatic neoplasms
neoplasm metastasis
Metastatic Prostate Carcinoma
antineoplastic combined chemotherapy protocols
prednisolone
prednisone
Abiraterone/Prednisone Regimen
drugs, generic
administration, oral
steroid 17-alpha-hydroxylase
neoplasms, hormone-dependent
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
drug interactions
pregnancy
breast feeding
survival analysis
drug evaluation, preclinical
androstenes
androstenols
androstenes
androstenols

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Hormonotherapie-acetate-d-abiraterone
2019
false
false
false
France
Drug-Related side effects and adverse reactions
Abiraterone Acetate
abiraterone
androgen antagonists
androgen antagonists
prostatic neoplasms
prostatic neoplasms, Castration-Resistant
metastatic castration resistant prostate cancer
administration, oral
Common Terminology Criteria for Adverse Events
continuity of patient care
Drug-Related side effects and adverse reactions
patient education as topic
risk factors
guidelines for drug use
Abiraterone Acetate

---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68244a-fra.php
2018
false
false
false
Canada
French
pharmacovigilance note
antineoplastic combined chemotherapy protocols
fractures, bone
radium ra 223 dichloride
Abiraterone Acetate
prednisone
prednisolone
antineoplastic agents
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
bone neoplasms
Contraindications, Drug
cause of death
radium
radioisotopes

---
https://www.has-sante.fr/portail/jcms/c_2857377/fr/zytiga
https://www.has-sante.fr/portail/jcms/c_2857377/fr/zytiga-acetate-d-abiraterone-inhibiteur-de-la-synthese-des-androgenes
2018
false
false
false
false
France
French
evaluation of the transparency committee
prostatic neoplasms
prostate cancer
neoplasms, hormone-dependent
neoplasm metastasis
treatment outcome
administration, oral
adult
insurance, health, reimbursement
abiraterone
androgen antagonists
antineoplastic combined chemotherapy protocols
guidelines for drug use
zytiga
Abiraterone Acetate

---
https://www.ema.europa.eu/medicines/human/EPAR/Zytiga
2018
false
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Abiraterone Acetate
Abiraterone Acetate
drug interactions
steroid 17-alpha-hydroxylase
clinical trials, phase iii as topic
survival analysis
drug evaluation, preclinical
treatment outcome
drug approval
administration, oral
abiraterone
prostatic neoplasms
adult
neoplasm metastasis
drug therapy, combination

---
http://www.has-sante.fr/portail/jcms/c_2755479/fr/zytiga
2017
false
false
false
France
French
evaluation of the transparency committee
Abiraterone Acetate
insurance, health, reimbursement
treatment outcome

---
https://www.has-sante.fr/portail/jcms/c_2755491/fr/zytiga
2017
false
France
French
Abiraterone Acetate
antineoplastic combined chemotherapy protocols
evaluation of the transparency committee
disease progression
steroid 17-alpha-hydroxylase
treatment outcome
administration, oral
abiraterone
prostatic neoplasms, Castration-Resistant
adult
neoplasm metastasis

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zytiga-3799.html
2016
false
Canada
English
French
Abiraterone Acetate
evaluation of the transparency committee
prostatic neoplasms
neoplasm metastasis
androgen antagonists
abiraterone
administration, oral
steroid 17-alpha-hydroxylase
antineoplastic combined chemotherapy protocols
treatment outcome
Cost-Benefit analysis
clinical trials, phase iii as topic
drug evaluation

---
http://www.has-sante.fr/portail/jcms/c_1735878/fr/jevtana-xtandi-et-zytiga-cabazitaxel-enzalutamide-et-abiraterone-des-progres-therapeutiques-pour-certains-cancers-metastatiques-de-la-prostate-fiche-bum
2014
true
France
French
cabazitaxel
cabazitaxel
infusions, intravenous
neoplasm metastasis
prostatic neoplasms
antineoplastic agents
guidelines for drug use
administration, oral
enzalutamide
anti-androgens
androgen antagonists
antineoplastic agents, hormonal
abiraterone
steroid 17-alpha-hydroxylase
enzyme inhibitors
drug therapy, combination
survival analysis
phenylthiohydantoin
taxoids
Abiraterone Acetate

---
http://www.has-sante.fr/portail/jcms/c_1231590/zytiga
http://www.has-sante.fr/portail/jcms/c_1622341/fr/zytiga
http://www.has-sante.fr/portail/jcms/c_1622340/fr/zytiga-12062013-avis-ct12826
2013
false
France
French
guidelines for drug use
Abiraterone Acetate
Abiraterone Acetate
administration, oral
insurance, health, reimbursement
neoplasm metastasis
prostatic neoplasms
adult
abiraterone
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
survival analysis
drug therapy, combination
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1294088/zytiga-synthese-29022012
http://www.has-sante.fr/portail/jcms/c_1239130/zytiga-29022012-ct11654
http://www.has-sante.fr/portail/jcms/c_1294184/zytiga-abiraterone-inhibiteur-de-la-biosynthese-des-androgenes
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
Abiraterone Acetate
abiraterone
prostatic neoplasms
neoplasm metastasis
administration, oral
insurance, health, reimbursement
drug therapy, combination
clinical trials, phase iii as topic
treatment outcome
survival analysis
prednisone
prednisolone
androgen antagonists

---
http://www.has-sante.fr/portail/jcms/c_1357758/jevtana-et-zytiga-un-progres-therapeutique-modere-pour-certains-cancers-metastatiques-de-la-prostate-fiche-bum
http://www.has-sante.fr/portail/jcms/c_1357763/bum-jevtana-zytiga
2012
false
France
French
Abiraterone Acetate
prostatic neoplasms
neoplasm metastasis
evaluation of the transparency committee
guidelines for drug use
taxoids
antineoplastic agents
cabazitaxel

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.